Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
WuXi AppTec Co., Ltd. (stock code: 603259.SH / 02359.HK), a leading global pharmaceutical and medical device open-access capability and technology...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announces the...
STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product manufacturing facility in Shanghai Pilot ...
Three of WuXi AppTec Laboratory Testing Division's facilities, Drug Safety Testing, Bioanalytical Services and Medical Device Testing, recently...
STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus, a Swiss biotech company, announce they have formed an exclusive ...
WuXi AppTec Co., Ltd. ("WuXi AppTec" or "the Company"; Stock code: 603259.SH/2359.HK) today announced the listing of approximately 116 million...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations,...
WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that...
WuXi AppTec announces today that its Laboratory Testing Division's new Medical Device Testing Center opens today in Suzhou, China. This marks the...
WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate®) for metastatic colorectal...
WuXi AppTec (603259.SH), a leading global pharmaceutical and medical device open-access capability and technology platform company, today announces...
STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - and Antengene Corporation, a biopharmaceutical company, recently announced a ...
STA Pharmaceutical Co., Ltd. (WuXi STA), a subsidiary of WuXi AppTec, congratulates its partner Ascletis for receiving approval from National Drug...
WuXi AppTec Co., Ltd. ("WuXi AppTec" or "the Company"; Stock Code: 603259), a leading global pharmaceutical and medical device open-access capability ...
STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient (API) R&D and...
STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), announces that it has signed an investment agreement with the government of...
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced the opening...
STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule...
WuXi Biologics (2269.HK), a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...
STA Pharmaceutical Co., Ltd. (STA) - a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule...
STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec subsidiary and the leading open-access capability and technology platform for small molecule...
WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec Affiliate, today...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.